Anupam Rasayan's open offer for Bliss GVS Pharma updated with PAC addendum
Anupam Rasayan Limited, the acquirer, submitted an addendum to both the Public Announcement and the Detailed Public Statement for its open offer to acquire Bliss GVS Pharma Limited. The addendum specifically addresses the addition of a Public Announcement Committee (PAC), a mandatory governance structure under the SEBI Takeover Regulations. The filing was notified to the NSE on 19 July 2026. The parties and offer valuation remain undisclosed in the available public record.
Why it mattersOpen offer addenda for PAC appointment signal continued regulatory compliance under takeover code; confirm whether this reflects a delay, condition precedent satisfaction, or material change triggering fresh disclosure under SEBI (SOTI) Regulations, 2011.
Counsel—
SectorPharma & Healthcare
[object Object][object Object][object Object][object Object][object Object][object Object]
Sources
- NSE Archives - Corporate · official
- Bar & Bench
- BSE corporate announcements · official
- NSE corporate announcements · official
- CCI combination orders · official
Related deals
- Anupam Rasayan India acquires controlling stake in Bliss GVS Pharma; Kanga & Co advises sellers28 Oct 2026
- Fortis Healthcare Limited: Press Release28 Oct 2026 · ₹277 Cr
- Fortis Healthcare Limited: Acquisition28 Oct 2026
- ThinkLaw advises Jagsonpal Pharma on acquiring Group Pharma's wellness portfolio27 Oct 2026
- Mankind Pharma Limited: Scheme of Arrangement26 Oct 2026
- Mankind Pharma Limited: Scheme of Arrangement26 Oct 2026